Severe coronavirus disease 2019 (COVID-19) pneumonia patients treated successfully with a combination of lopinavir/ritonavir plus favipiravir: Case series.

Hayato Koba Taro YonedaTomoya KanedaTsukasa UedaHideharu KimuraKazuo Kasahara

Published in: Clinical case reports (2020)

The combination therapy of Lopinavir/Ritonavir plus Favipiravir might be a treatment option for patients with COVID-19. Serum ferritin levels and lymphocytopenia are promising markers for disease severity and disease progression that are commonly available in general clinical practice.

Keyphrases

combination therapy
coronavirus disease
clinical practice
sars cov
antiretroviral therapy
respiratory syndrome coronavirus
early onset
extracorporeal membrane oxygenation
acute respiratory distress syndrome